Cabazitaxel STADA

Medicinal product

(Invented) name

Cabazitaxel STADA

Active substance (s)

Kabazitakselis

Strength

20 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01CD04, Cabazitaxel

Marketing authorisation holder

STADA Arzneimittel AG, Vokietija

Date of authorisation

2023-06-08

Date of renewal

Documents

5187 Pakuotės lapelis 2025 05 09.docx

5187 Cabazitaxel_STADA PCS PL 2025 05 09.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

DK/H/3133/001/E/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

1 ml koncentrato yra:	1 ml
Kabazitakselis	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111108	97219	1097219	flakonas	3 ml N1		Receptinis	LT/1/23/5187/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-06-08	Registruotas